Innospark Ventures Team
Photo of Matt Fates, Partner at Innospark Ventures
Matt Fates
Sweet spot: $1.5M
Range: $500K - $4.0M
Investors in Boston / New England, Investors in New York (NY), Investors in Toronto (Ontario), Investors in Washington (DC), Investors in Philadelphia (PA)
Investors in Analytics (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in AI (Seed), Investors in Analytics (Seed), Investors in Analytics (Seed), Investors in AI (Seed), Investors in Analytics (Seed), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Analytics (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in New York City (Other Lists), Investors in Health IT (Seed), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in SaaS (Seed), Investors in British Columbia (Other Lists), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in DeepTech (Seed), Investors in DeepTech (Seed), Investors in DeepTech (Seed), Investors in Analytics (Pre-seed), Investors in DeepTech (Seed), Investors in DeepTech (Seed), Investors in DeepTech (Pre-seed), Investors in AI (Pre-seed), Investors in Health IT (Pre-seed), Investors in Analytics (Pre-seed), Investors in Analytics (Pre-seed), Investors in AI (Pre-seed), Investors in Analytics (Pre-seed), Investors in AI (Pre-seed), Investors in BioTech (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Analytics (Pre-seed), Investors in SaaS (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health IT (Pre-seed), Investors in SaaS (Pre-seed), Investors in SaaS (Pre-seed), Investors in SaaS (Pre-seed), Investors in Health IT (Pre-seed), Investors in SaaS (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in BioTech (Pre-seed), Investors in SaaS (Seed)
to see your intro paths to Matt
JK
Jeff Knox
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in AI (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Generative Tech/AI (Pre-seed), Investors in Generative Tech/AI (Seed), Investors in Generative Tech/AI (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
to see your intro paths to Jeff
Photo of Mark Legare, Senior Associate at Innospark Ventures
Mark Legare
Innospark Ventures·Senior Associate
Sweet spot: $1.5M
Range: $50K - $4.0M
Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in AI (Seed), Investors in AI (Seed), Investors in Health IT (Series A), Investors in FinTech (Seed), Investors in AI (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in SaaS (Seed), Investors in Robotics (Seed), Investors in Health & Hospital Services (Seed), Investors in AI (Series A), Investors in FinTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in SaaS (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Robotics (Pre-seed), Investors in AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Pre-seed), Investors in SaaS (Pre-seed), Investors in Health IT (Pre-seed), Investors in FinTech (Pre-seed), Investors in Robotics (Pre-seed), Investors in SaaS (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in FinTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in SaaS (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed)
to see your intro paths to Mark
Photo of Venkat Srinivasan, Managing Director at Innospark Ventures
Venkat Srinivasan
Innospark Ventures·Managing Director
Sweet spot: $0
Range: $0 - $0
Investors in Boston (MA), Investors in Boston / New England
Investors in AI (Series B), Investors in Education (Series B), Investors in Education (Series A), Investors in Enterprise (Series B), Investors in Security (Series B), Investors in Security (Series A), Investors in Health & Hospital Services (Series B), Investors in AI (Series A), Investors in SaaS (Series B), Investors in Enterprise (Series A), Investors in Health & Hospital Services (Series A), Investors in AI (Series A), Investors in Education (Series A), Investors in Enterprise (Series A), Investors in SaaS (Series A), Investors in Security (Series A), Investors in Health & Hospital Services (Series A), Investors in AI (Series B), Investors in Education (Series B), Investors in Enterprise (Series B), Investors in Security (Series B), Investors in SaaS (Series B), Investors in Health & Hospital Services (Series B), Investors in Boston / New England (Other Lists), Investors in Education (Pre-seed), Investors in Security (Pre-seed), Investors in AI (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Pre-seed), Investors in Education (Pre-seed), Investors in Enterprise (Pre-seed), Investors in SaaS (Pre-seed), Investors in Enterprise (Pre-seed), Investors in SaaS (Pre-seed), Investors in Security (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in SaaS (Series A)
to see your intro paths to Venkat